Sung Tzu-Ling, Rice Andrew P
Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030, USA.
Retrovirology. 2006 Oct 2;3:66. doi: 10.1186/1742-4690-3-66.
The latent reservoir of human immunodeficiency virus type 1 (HIV-1) in resting CD4+ T cells is a major obstacle to the clearance of infection by highly active antiretroviral therapy (HAART). Recent studies have focused on searches for adjuvant therapies to activate this reservoir under conditions of HAART. Prostratin, a non tumor-promoting phorbol ester, is a candidate for such a strategy. Prostratin has been shown to reactivate latent HIV-1 and Tat-mediated transactivation may play an important role in this process. We examined resting CD4+ T cells from healthy donors to determine if prostratin induces Cyclin T1/P-TEFb, a cellular kinase composed of Cyclin T1 and Cyclin-dependent kinase-9 (CDK9) that mediates Tat function. We also examined effects of prostratin on Cyclin T2a, an alternative regulatory subunit for CDK9, and 7SK snRNA and the HEXIM1 protein, two factors that associate with P-TEFb and repress its kinase activity.
Prostratin up-regulated Cyclin T1 protein expression, modestly induced CDK9 protein expression, and did not affect Cyclin T2a protein expression. Although the kinase activity of CDK9 in vitro was up-regulated by prostratin, we observed a large increase in the association of 7SK snRNA and the HEXIM1 protein with CDK9. Using HIV-1 reporter viruses with and without a functional Tat protein, we found that prostratin stimulation of HIV-1 gene expression appears to require a functional Tat protein. Microarray analyses were performed and several genes related to HIV biology, including APOBEC3B, DEFA1, and S100 calcium-binding protein genes, were found to be regulated by prostratin.
Prostratin induces Cyclin T1 expression and P-TEFb function and this is likely to be involved in prostratin reactivation of latent HIV-1 proviruses. The large increase in association of 7SK and HEXIM1 with P-TEFb following prostratin treatment may reflect a requirement in CD4+ T cells for a precise balance between active and catalytically inactive P-TEFb. Additionally, genes regulated by prostratin were identified that have the potential to regulate HIV-1 replication both positively and negatively.
1型人类免疫缺陷病毒(HIV-1)在静息CD4+ T细胞中的潜伏储存库是高效抗逆转录病毒疗法(HAART)清除感染的主要障碍。最近的研究集中在寻找辅助疗法以在HAART条件下激活这个储存库。Prostratin是一种无肿瘤促进作用的佛波酯,是这种策略的一个候选药物。已表明Prostratin可重新激活潜伏的HIV-1,且Tat介导的反式激活可能在此过程中起重要作用。我们检测了来自健康供体的静息CD4+ T细胞,以确定Prostratin是否诱导细胞周期蛋白T1/正性转录延伸因子b(P-TEFb),P-TEFb是一种由细胞周期蛋白T1和细胞周期蛋白依赖性激酶9(CDK9)组成的细胞激酶,介导Tat功能。我们还检测了Prostratin对细胞周期蛋白T2a(CDK9的另一种调节亚基)、7SK小核RNA(snRNA)和HEXIM1蛋白的影响,7SK snRNA和HEXIM1蛋白是与P-TEFb结合并抑制其激酶活性的两个因子。
Prostratin上调细胞周期蛋白T1蛋白表达,并适度诱导CDK9蛋白表达,但不影响细胞周期蛋白T2a蛋白表达。虽然Prostratin在体外上调了CDK9的激酶活性,但我们观察到7SK snRNA和HEXIM1蛋白与CDK9的结合大幅增加。使用带有和不带有功能性Tat蛋白的HIV-1报告病毒,我们发现Prostratin刺激HIV-1基因表达似乎需要功能性Tat蛋白。进行了微阵列分析,发现包括载脂蛋白B mRNA编辑酶催化多肽样3B(APOBEC3B)、防御素1(DEFA1)和S100钙结合蛋白基因在内的几个与HIV生物学相关的基因受Prostratin调节。
Prostratin诱导细胞周期蛋白T1表达和P-TEFb功能,这可能参与Prostratin对潜伏HIV-1前病毒的重新激活。Prostratin处理后7SK和HEXIM1与P-TEFb结合的大幅增加可能反映了CD4+ T细胞中对活性和催化无活性的P-TEFb之间精确平衡的需求。此外,鉴定出了受Prostratin调节的基因,这些基因具有正向和负向调节HIV-1复制的潜力。